Personalized cancer testing Rational Therapeutics offers EVA-PCD, a chemosensitivity assay that personalizes cancer treatment by predicting which therapies are most effective and least toxic, presenting an opportunity to partner with hospitals and clinics seeking precision medicine solutions.

Clinical consultation access Led by Dr. Nagourney, the organization provides on-site hematologist/oncologist clinical consultations, enabling collaboration for joint case reviews, second opinions, and integrated care pathways with cancer centers.

Global sample workflow Samples arrive from around the world and must be processed quickly (24-36 hours). This creates a sales angle for international laboratories and courier networks that can ensure rapid, reliable specimen transport and turnaround time.

Regulatory credibility As a fully accredited federal and state licensed laboratory with two decades of experience, Rational Therapeutics can leverage compliance and quality assurances when pitching to large hospital systems and pharma partners for clinical trial testing.

Pharma collaboration The lab already offers services to pharmaceutical companies to determine drug efficacy across tumor types, presenting a channel for expanding partnerships in drug development, translational research, and companion diagnostics.